Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer

Final draft guidance

Final appraisal document (PDF 314 KB)

Public committee slides (PDF 704 KB)

Draft guidance

Appraisal consultation document (PDF version) (PDF 355 KB)

Appraisal consultation document (online commenting)

Public committee slides (PDF 1.04 MB)

Final scope (PDF 179 KB)

Final stakeholder list (PDF 229 KB)

Expected publication

TA600 FAD (PDF 287 KB)

Committee slides (TA600) (PDF 786 KB)

Managed access agreement (TA600) (PDF 352 KB)

Equality Impact Assessment (Guidance development) (TA600) (PDF 145 KB)

Final scope (TA600) (PDF 237 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (TA600) (PDF 260 KB)